SAN FRANCISCO--(BUSINESS WIRE)--Through integration with Multiply Labs' robotic technology, Thermo Fisher Scientific’s ... that automated and manual cell expansion processes are statistically ...

Thermo Fisher Scientific and Charles River, has been successfully completed. The data from this project indicate that manual cell therapy manufacturing tasks (and in particular, cell expansion ...

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, and the University of California, San Francisco (UCSF), will accelerate advanced cell therapies for difficult to treat ...

On a quest to automate manual ... in Thermo Fisher Scientific and Charles River Laboratories, the companies said Thursday. With Multiply in charge of robotics and UCSF covering the cell ...

A new 44,000-square-foot, state-of-the-art cell therapy development, manufacturing and collaboration center will be located in leased space on UCSF’s Mission Bay campus. Photo by Matt Beardsley Thermo ...

entered into a collaboration with Thermo Fisher Scientific which aims to accelerate the availability of new cell and exosome therapies that have the potential to greatly improve the treatment of ...

but lawyers for her family argued that Thermo Fisher Scientific Inc., of Waltham, Massachusetts, has continued to commercialize the results well after the origins of the HeLa cell line became well ...

In 2021, Lacks' estate filed a lawsuit against Thermo Fisher Scientific, alleging that the ... profits obtained by commercializing the HeLa cell line to the Estate of Henrietta Lacks." ...

Thermo Fisher Scientific Inc. has settled a lawsuit with ... amount of its net profits obtained by commercializing the HeLa cell line to the Estate of Henrietta Lacks" and to be permanently ...

but lawyers for her family argued that Thermo Fisher Scientific Inc., of Waltham, Massachusetts, has continued to commercialize the results well after the origins of the HeLa cell line became well ...